EconPapers    
Economics at your fingertips  
 

Leptin-regulated endocannabinoids are involved in maintaining food intake

Vincenzo Di Marzo, Sravan K. Goparaju, Lei Wang, Jie Liu, Sándor Bátkai, Zoltán Járai, Filomena Fezza, Grant I. Miura, Richard D. Palmiter, Takayuki Sugiura and George Kunos ()
Additional contact information
Vincenzo Di Marzo: Endocannabinoid Research Group, Istituto per la Chimica di Molecole di Interesse Biologico, CNR
Sravan K. Goparaju: Medical College of Virginia, Virginia Commonwealth University
Lei Wang: Medical College of Virginia, Virginia Commonwealth University
Jie Liu: Medical College of Virginia, Virginia Commonwealth University
Sándor Bátkai: Medical College of Virginia, Virginia Commonwealth University
Zoltán Járai: Medical College of Virginia, Virginia Commonwealth University
Filomena Fezza: Endocannabinoid Research Group, Istituto per la Chimica di Molecole di Interesse Biologico, CNR
Grant I. Miura: University of Washington
Richard D. Palmiter: University of Washington
Takayuki Sugiura: Faculty of Pharmaceutical Sciences, Teikyo University
George Kunos: Medical College of Virginia, Virginia Commonwealth University

Nature, 2001, vol. 410, issue 6830, 822-825

Abstract: Abstract Leptin is the primary signal through which the hypothalamus senses nutritional state and modulates food intake and energy balance1. Leptin reduces food intake by upregulating anorexigenic (appetite-reducing) neuropeptides, such as α-melanocyte-stimulating hormone2,3, and downregulating orexigenic (appetite-stimulating) factors, primarily neuropeptide Y4. Genetic defects in anorexigenic signalling, such as mutations in the melanocortin-4 (ref. 5) or leptin receptors6, cause obesity. However, alternative orexigenic pathways maintain food intake in mice deficient in neuropeptide Y7. CB1 cannabinoid receptors8 and the endocannabinoids anandamide and 2-arachidonoyl glycerol are present in the hypothalamus9, and marijuana10 and anandamide11,12 stimulate food intake. Here we show that following temporary food restriction, CB1 receptor knockout mice eat less than their wild-type littermates, and the CB1 antagonist SR141716A reduces food intake in wild-type but not knockout mice. Furthermore, defective leptin signalling is associated with elevated hypothalamic, but not cerebellar, levels of endocannabinoids in obese db/db and ob/ob mice and Zucker rats. Acute leptin treatment of normal rats and ob/ob mice reduces anandamide and 2-arachidonoyl glycerol in the hypothalamus. These findings indicate that endocannabinoids in the hypothalamus may tonically activate CB1 receptors to maintain food intake and form part of the neural circuitry regulated by leptin.

Date: 2001
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.nature.com/articles/35071088 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:410:y:2001:i:6830:d:10.1038_35071088

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/35071088

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-22
Handle: RePEc:nat:nature:v:410:y:2001:i:6830:d:10.1038_35071088